US20200000615A1 - Intestinal barrier sleeve with expandable anchor section - Google Patents
Intestinal barrier sleeve with expandable anchor section Download PDFInfo
- Publication number
- US20200000615A1 US20200000615A1 US16/403,711 US201916403711A US2020000615A1 US 20200000615 A1 US20200000615 A1 US 20200000615A1 US 201916403711 A US201916403711 A US 201916403711A US 2020000615 A1 US2020000615 A1 US 2020000615A1
- Authority
- US
- United States
- Prior art keywords
- sleeve
- subject
- section
- expanding
- gastrointestinal tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000005027 intestinal barrier Anatomy 0.000 title claims abstract description 25
- 230000007358 intestinal barrier function Effects 0.000 title claims abstract description 25
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims description 11
- 210000001187 pylorus Anatomy 0.000 claims description 10
- 210000000813 small intestine Anatomy 0.000 claims description 10
- 210000002784 stomach Anatomy 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 238000004891 communication Methods 0.000 claims description 7
- 239000000560 biocompatible material Substances 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 229920000544 Gore-Tex Polymers 0.000 claims description 3
- 229920000271 Kevlar® Polymers 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 229910000831 Steel Inorganic materials 0.000 claims description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
- 239000004917 carbon fiber Substances 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 239000004761 kevlar Substances 0.000 claims description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 3
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- -1 polypropylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229910001285 shape-memory alloy Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010959 steel Substances 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 239000010936 titanium Substances 0.000 claims description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 claims 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 2
- 238000011282 treatment Methods 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 208000008589 Obesity Diseases 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 206010059186 Early satiety Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000012277 endoscopic treatment Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
- A61F5/0079—Pyloric or esophageal obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/045—Stomach, intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0008—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0019—Angular shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/005—Rosette-shaped, e.g. star-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0067—Three-dimensional shapes conical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
Definitions
- the present application relates to devices and corresponding methods for the endoscopic treatment of obesity, diabetes, hyperlipidemia and other ailments of the digestive system.
- Obesity is a growing health concern which is estimated to be directly responsible for over $147 B in healthcare costs or 3%-8% of the overall healthcare costs of certain countries.
- Invasive therapies such as gastric bypass and stomach bands and stapling have been in use in the United States for years with limited success.
- such therapies often require surgical procedures, can damage the patient, and are in some cases irreversible.
- endoscopic therapies have been proposed for the treatment of obesity which, unlike invasive therapies, are minimally invasive and are often reversible.
- inflatable balloons have been inserted into the stomach to decrease the accommodation of the stomach in the hopes of creating early satiety and thus decreasing caloric intake.
- intestinal barrier sleeves anchored in the small intestines have been used to decrease the absorptive surface of digestion in the small intestines with promising results.
- These therapies as currently in use, however, are significantly limited in their efficacy as well as safety. Indeed, the failure rate for intestinal barrier sleeves is relatively high, primarily due to patient intolerance and GI bleeding particularly at the anchorage points in the intestines.
- an intestinal barrier sleeve in one aspect, includes an expanding anchor section coupled to a tubular section at an interface there between at one promixal end of the sleeve, the expanding anchor section expandable from at least one collapsed position to at least one expanded position, wherein in the collapsed position the expanding anchor section has a compact shape that allows the sleeve to be placed into a subject's gastrointestinal tract endoscopically and in the second position the expanded anchor section retains the sleeve in the subject's gastrointestinal tract in the stomach.
- the expanding section has a conical or lotus flower shape with a hole therein at a narrow end of the conical shape, and wherein the conical shape is in communication with a lumen of the tubular section through the hole.
- the conical shape may comprise at least one of the following specific shapes: a bowl shape, a saucer shape, a funnel shape, a trumpet shape, a bell shape, and a star shape.
- the expanding section comprises a plurality of petal-like elements extending radially from the narrow end of the conical shape.
- the expanding section may comprise a webbing, with the petal-like elements coupled to each other with the webbing.
- the expanding section comprises a plurality of backbone elements extending radially from the narrow end of the conical shape. In one embodiment, the expanding section further comprises a plurality of petal-like elements extending radially from the narrow end of the conical shape and wherein the backbone elements are joined to the petal-like elements.
- the petal-like elements are comprised of a soft, non-digestible, acid-resistant, non-abrasive plastic or rubber material.
- the expanding section further comprises a ring structure and wherein at least one of the petal-like elements and the backbone elements are coupled to each other via the ring structure.
- the tubular section is sufficiently flexible so that when the tubular section is placed such that the tubular section extends through the subject's pyloric sphincter, the sleeve will not interfere with the function of the subject's pyloric sphincter.
- a method for treating a subject with an ailment includes the steps of: maintaining an intestinal barrier sleeve in a collapsed position, wherein the sleeve comprises an expanding section coupled to a tubular section at an interface there between, the expanding section expandable from at least the first collapsed position to at least one expanded position; placing the sleeve with the collapsing section in the first position into a subject's gastrointestinal tract endoscopically; and expanding the expanding section within the subject's gastrointestinal tract therewith retaining the sleeve in the subject's gastrointestinal tract.
- the sleeve is placed in the subject's gastrointestinal tract so that the expanding section is located within the subject's pyloric canal.
- the sleeve is placed in the subject's gastrointestinal tract so that the tubular section passes through the subject's pyloric sphincter and extends into the subject's small intestine.
- the tubular section is sufficiently flexible so that the sleeve will not interfere with the function of the subject's pyloric sphincter.
- the expanding section has a conical shape with a hole therein at a narrow end of the conical shape, and wherein the conical shape is in communication with a lumen of the tubular section through the hole.
- the expanding section comprises a plurality of backbone elements extending radially from the narrow end of the conical shape.
- the expanding section further comprises a plurality of petal-like elements extending radially from the narrow end of the conical shape and wherein the backbone elements are joined to the petal-like elements.
- the expanding section comprises a webbing and wherein the petal-like elements are coupled to each other with the webbing.
- the expanding section further comprises a ring structure and wherein at least one of the petal-like elements and the backbone elements are coupled to each other via the ring structure.
- an intestinal barrier sleeve in another aspect, includes an expanding section coupled to a tubular section at an interface there between, the expanding section expandable from at least a first collapsed position to at least one expanded position, wherein the expanding section has a conical shape with a hole therein at a narrow end of the conical shape, and wherein the conical shape is in communication with a lumen of the tubular section through the hole, and wherein the expanding section comprises a plurality of petal-like elements extending radially from the narrow end of the conical shape, the petal-like elements interconnected with a webbing to form the conical shape.
- FIG. 1 is a plan view showing an intestinal barrier sleeve according to at least one embodiment of the invention in situ in a subject's gastrointestinal track.
- FIG. 2 is a side view of a proximal end of the intestinal barrier sleeve according to at least one embodiment of the invention with the proximal end disposed in a collapsed position.
- FIG. 3 is a front view of a proximal end of the intestinal barrier sleeve according to at least one embodiment of the invention with the proximal end disposed in a collapsed position.
- FIG. 4 is a side view of a proximal end of the intestinal barrier sleeve according to at least one embodiment of the invention with the proximal end disposed in an expanded position.
- FIG. 5 is a front view of a proximal end of the intestinal barrier sleeve according to at least one embodiment of the invention with the proximal end disposed in an expanded position.
- the present application provides generally an intestinal barrier sleeve that is expandable from at least one collapsed position to at least one expanded position for placement in a subject's gastrointestinal tract. Expansion of the expandable element results in the sleeve being lodged in the subject's GI tract therewith functionally retaining the sleeve therein.
- this design allows the sleeve to be installed without the need to affix or otherwise join the sleeve directly to the GI tract, for example, with a staple or suture, the sleeve may be so attached if desired.
- the intestinal barrier sleeve includes an expanding section 106 coupled to an elongated tubular section 104 at interface 108 .
- the expanding section 106 When expanded, the expanding section 106 generally has a conical shape with a hole therein at the narrow end of the conical section, which is in communication with the lumen of the tubular section 104 .
- the type of conical shape may vary.
- the cone may be bowl or saucer shaped, funnel shaped, trumpet shaped, bell shaped, star shaped, etc., or a combination thereof, such as a bowl-star shape as shown.
- the sleeve is preferably inserted endoscopically into the subject's gastrointestinal (GI) tract so that the tubular section 104 extends through the pyloric sphincter of the subject's stomach 100 into the duodenum 102 so that the pyloric sphincter acts directly onto the tubular section 104 of the sleeve at or just below the interface 108 .
- the expanding section 106 and optionally the interface 108 are located within the pyloric canal of the subject's stomach 100 .
- the expanding section 106 preferably provides sufficient resistance to retain the sleeve within the subject's GI tract without the need to anchor or otherwise affix the sleeve directly to the walls of the subject's GI tract.
- the tubular section 104 extends into the subject's small intestine an amount sufficient to reduce further digestion and/or absorption of partially digested food by the small intestine.
- the tubular section 104 preferably extends beyond the interface 108 by about 20 inches to about 28 inches. In this regard, the tubular section 104 is preferably impermeable with respect to partially digested foods.
- the distal end of the sleeve (the end of the tubular farthest away from the stomach, i.e., opposite the interface 108 ), may be weighted with several small focal weights on the end of the sleeve itself. This may mitigate the potential retrograde migration of the sleeve.
- the sleeve may be manufactured from a variety and/or a combination of biocompatible and non-biocompatible materials, such as polyester, Gortex, polytetrafluoroethyline (PTFE), polyethelene, polypropylene, polyurethane, silicon, steel, stainless steel, titanium, Nitinol, or other shape memory alloys, copper, silver, gold, platinum, Kevlar fiber, carbon fiber, etc.
- non-biocompatible materials may come into contact with the anatomic structure, the components made from the non-biocompatible materials may be covered or coated with a biocompatible material.
- the sleeve is preferably made in part of a biocompatible polymer sufficiently flexible to allow a user to navigate therewith though a subject's GI tract to the site of interest.
- the cross section of the tubular section 104 has sufficiently thin walls so that in conjunction with the flexibility/elasticity of the material the sleeve will not interfere with the function of the subject's pyloric sphincter.
- the intestinal barrier sleeve, particularly the expanding section 106 is capable of being expanded between at least two positions: a collapsed position and an expanded position.
- the expanding section 106 In the collapsed position ( FIGS. 2-3 ), the expanding section 106 has a smaller profile (as compared to the expanded position ( FIGS. 4-5 )) for the sleeve to be located in the GI track endoscopically, for example, through a catheter.
- the expanding section 106 may be biased toward either position. That is, the expanding section 106 may he biased toward the expanded position so that the expanding section 106 remains expanded absent any compressive forces placed thereon. Similarly, the section 106 may be biased toward the collapsed position so that the section 106 remains collapsed absent any contrary forces.
- the expanding section 106 may be fixed in the expanded position against the bias using, for example, using mechanical interlocking components.
- the structure of section 106 may be deformed beyond the elastic limits of the material so that section 106 is permanently deformed into the expanded position.
- the expanding section 106 preferably includes a plurality of petal-like elements 202 , 204 , 206 , 208 extending radially from the narrow end of the expanding section 106 .
- the petal-like elements may vary in shape.
- the petal-like elements may have an almond shape, as show, an elliptical shape, a rectangular shape, etc. These shapes may have planer or concave/convex surfaces.
- the petal-like elements 202 , 204 , 206 , 208 may further or alternatively include a backbone element 214 also extending radially from the interface 108 .
- Backbone elements 214 may be straight or preferably have an arc so that the shape of section 106 conforms to the subject's anatomy at site of interest.
- the petal-like elements 202 , 204 , 206 , 208 and/or the backbone thereof may further be coupled to each other via a ring structure 402 .
- the petal-like elements 202 , 204 , 206 , 208 and/or the backbone thereof may also be coupled to each other with webbing 216 to form the conical shaped noted above.
- the petahlike elements 202 , 204 206 , 208 and/or the backbone thereof may terminate at the outward end in a bulbous element 210 .
- the bulbous element 210 may be spherical, ellipsoidal, or the like. Bulbous elements 210 may also include a through hole therein.
- the petal-like elements 202 , 204 , 206 , 208 overlap with each in the collapsed position to allow the expanding section 106 to be placed in a compact collapsed position.
- this collapsed position may be maintained, for example, by placing the sleeve within the lumen of a placement catheter.
- Other means may be used to maintain the collapsed position, including securing bulbous ends 210 to each other, for example, using the through holes therein.
- expansion of section 106 in situ may be achieved by simply extruding the sleeve out from the placement catheter or otherwise removing the restrictive forces on the petal-like elements 202 , 204 , 206 , 208 and/or the backbone thereof at the site of interest so that the spring-like elasticity of these elements causes section 106 to assume an expanded position.
- the sleeve is preferably just as easily removed from the site of interest endoscopically. To do so, the restrictive forces are replaced on petal-like elements 202 ., 204 , 206 , 208 and/or the backbone thereof to draw these elements together at their outward ends. This may be achieved by pulling the sleeve into the placement catheter or otherwise placing restrictive forces on the petal-like elements 202 , 204 , 206 , 208 and/or the backbone thereof.
- the petal-like elements 202 , 204 , 206 , 208 may partially overlap in the expanded position.
- the amount of the overlap will vary depending on the degree of the expansion. Specifically, the amount of the overlap will be smaller as the ends of the petal-like elements 202 , 204 , 206 , 208 are moved farther away from each other as the expanding section 106 expands, as shown in FIG. 5 .
- the petal-like elements 202 , 204 , 206 . 208 and/or the backbone thereof may be hinged to the tubular member 104 at the interface 108 to facilitate the expansion/collapse of these elements.
- the petal-like elements 202 , 204 , 206 208 and the webbing 216 are preferably connected continuously so that there are no breaks in between in the petal-like elements 202 , 204 , 206 , 208 .
- This may be achieved by molding the petal-like elements 202 , 204 , 206 , 208 , the backbone 214 thereof, the webbing 216 , and/or the ring structure 402 as a unit.
- these individual elements may be distinguished from each other by their respective thicknesses and the resulting performance characteristics thereof.
- the webbing 216 may have a thickness so that it performs more like a film.
- the webbing 216 may functionally provide a flexible, impermeable layer that allows the petal-like elements 202 , 204 , 206 , 208 and/or the backbone thereof to move freely essentially without appreciable restriction placed thereon by the webbing 216 .
- the petal-like elements 202 , 204 , 206 , 208 and/or the backbone thereof on the other hand functionally provide the expanded position bias noted above and also spread the load as a result of this bias in situ on the subject's anatomy.
- the dimensions of these elements collectively allow the elements to provide sufficient elasticity to restrict the sleeve from unintentionally moving down the subject's GI track while also ensuring that the load placed on the subject's pyloric canal is spread sufficiently thereon to prevent or otherwise ameliorate the likelihood of any complications that may result from any excessive pressure.
- the present application provides generally methods for treading ailments using the intestinal barrier sleeve(s) disclosed herein, including obesity, diabetes, as well as other ailments associated with or otherwise implicating the small intestine.
- These treatments may begin by preparing the subject being treated for an endoscopic procedure, which may include administering general anesthesia.
- the sleeve may then be passed endoscopically through the subject's GI tract so that the expanding section 106 is located in the pyloric canal of the subject's stomach and so that the tubular section 104 extends into the subject's small intestine.
- expanding section 106 is allowed or caused to expand, for example, by removing any restriction on section 106 .
- section 106 may be extruded out from the placement catheter used to deliver the sleeve to the site of interest. Expansion of section 106 will keep the sleeve in place until removal is desired.
- the design of the sleeve allows the sleeve to be removed endoscopically with relative ease. To do so, the subject is similarly prepared for the endoscopic procedure and the sleeve is removed in the reverse direction from that in which the sleeve was placed.
Abstract
An intestinal barrier sleeve and corresponding treatments using the sleeve are provided herein. The sleeve generally includes an expanding section coupled to a tubular section at an interface there between. The expanding section is expandable from at least a first collapsed position to at least one expanded position, where the expanding section has a conical shape that when expanded retains the sleeve in the subject gastrointestinal tract. The expanding section may further include a plurality of petal-like elements extending radially from the narrow end of the conical shape and the petal-like elements may be interconnected with a webbing to form the conical shape.
Description
- The present application is a continuation of co-pending U.S. patent application Ser. No. 15/408,668, filed on Jan. 18, 2017, which is hereby incorporated herein by reference.
- The present application relates to devices and corresponding methods for the endoscopic treatment of obesity, diabetes, hyperlipidemia and other ailments of the digestive system.
- Obesity is a growing health concern which is estimated to be directly responsible for over $147 B in healthcare costs or 3%-8% of the overall healthcare costs of certain countries. Invasive therapies such as gastric bypass and stomach bands and stapling have been in use in the United States for years with limited success. In addition, such therapies often require surgical procedures, can damage the patient, and are in some cases irreversible.
- A number of endoscopic therapies have been proposed for the treatment of obesity which, unlike invasive therapies, are minimally invasive and are often reversible. For instance, inflatable balloons have been inserted into the stomach to decrease the accommodation of the stomach in the hopes of creating early satiety and thus decreasing caloric intake. Similarly, intestinal barrier sleeves anchored in the small intestines have been used to decrease the absorptive surface of digestion in the small intestines with promising results. These therapies as currently in use, however, are significantly limited in their efficacy as well as safety. Indeed, the failure rate for intestinal barrier sleeves is relatively high, primarily due to patient intolerance and GI bleeding particularly at the anchorage points in the intestines.
- Accordingly, there remains a need for improved endoscopic therapies for the treatment of obesity, diabetes and other ailments that are safer and more versatile than existing therapies.
- In one aspect, an intestinal barrier sleeve is provided that includes an expanding anchor section coupled to a tubular section at an interface there between at one promixal end of the sleeve, the expanding anchor section expandable from at least one collapsed position to at least one expanded position, wherein in the collapsed position the expanding anchor section has a compact shape that allows the sleeve to be placed into a subject's gastrointestinal tract endoscopically and in the second position the expanded anchor section retains the sleeve in the subject's gastrointestinal tract in the stomach.
- In some embodiments, the expanding section has a conical or lotus flower shape with a hole therein at a narrow end of the conical shape, and wherein the conical shape is in communication with a lumen of the tubular section through the hole. The conical shape may comprise at least one of the following specific shapes: a bowl shape, a saucer shape, a funnel shape, a trumpet shape, a bell shape, and a star shape.
- In some embodiments, the expanding section comprises a plurality of petal-like elements extending radially from the narrow end of the conical shape. The expanding section may comprise a webbing, with the petal-like elements coupled to each other with the webbing.
- In some embodiments, the expanding section comprises a plurality of backbone elements extending radially from the narrow end of the conical shape. In one embodiment, the expanding section further comprises a plurality of petal-like elements extending radially from the narrow end of the conical shape and wherein the backbone elements are joined to the petal-like elements. The petal-like elements are comprised of a soft, non-digestible, acid-resistant, non-abrasive plastic or rubber material.
- In one embodiment, the expanding section further comprises a ring structure and wherein at least one of the petal-like elements and the backbone elements are coupled to each other via the ring structure.
- In one embodiment, the tubular section is sufficiently flexible so that when the tubular section is placed such that the tubular section extends through the subject's pyloric sphincter, the sleeve will not interfere with the function of the subject's pyloric sphincter.
- In another aspect, a method for treating a subject with an ailment is provided that includes the steps of: maintaining an intestinal barrier sleeve in a collapsed position, wherein the sleeve comprises an expanding section coupled to a tubular section at an interface there between, the expanding section expandable from at least the first collapsed position to at least one expanded position; placing the sleeve with the collapsing section in the first position into a subject's gastrointestinal tract endoscopically; and expanding the expanding section within the subject's gastrointestinal tract therewith retaining the sleeve in the subject's gastrointestinal tract.
- In one embodiment, the sleeve is placed in the subject's gastrointestinal tract so that the expanding section is located within the subject's pyloric canal.
- In one embodiment, the sleeve is placed in the subject's gastrointestinal tract so that the tubular section passes through the subject's pyloric sphincter and extends into the subject's small intestine.
- In one embodiment, the tubular section is sufficiently flexible so that the sleeve will not interfere with the function of the subject's pyloric sphincter.
- In one embodiment, the expanding section has a conical shape with a hole therein at a narrow end of the conical shape, and wherein the conical shape is in communication with a lumen of the tubular section through the hole.
- In one embodiment, the expanding section comprises a plurality of backbone elements extending radially from the narrow end of the conical shape.
- In one embodiment, the expanding section further comprises a plurality of petal-like elements extending radially from the narrow end of the conical shape and wherein the backbone elements are joined to the petal-like elements.
- In one embodiment, the expanding section comprises a webbing and wherein the petal-like elements are coupled to each other with the webbing.
- In one embodiment, the expanding section further comprises a ring structure and wherein at least one of the petal-like elements and the backbone elements are coupled to each other via the ring structure.
- In another aspect, an intestinal barrier sleeve is provided that includes an expanding section coupled to a tubular section at an interface there between, the expanding section expandable from at least a first collapsed position to at least one expanded position, wherein the expanding section has a conical shape with a hole therein at a narrow end of the conical shape, and wherein the conical shape is in communication with a lumen of the tubular section through the hole, and wherein the expanding section comprises a plurality of petal-like elements extending radially from the narrow end of the conical shape, the petal-like elements interconnected with a webbing to form the conical shape.
- Additional aspects of the present invention will be apparent in view of the description which follows.
-
FIG. 1 is a plan view showing an intestinal barrier sleeve according to at least one embodiment of the invention in situ in a subject's gastrointestinal track. -
FIG. 2 is a side view of a proximal end of the intestinal barrier sleeve according to at least one embodiment of the invention with the proximal end disposed in a collapsed position. -
FIG. 3 is a front view of a proximal end of the intestinal barrier sleeve according to at least one embodiment of the invention with the proximal end disposed in a collapsed position. -
FIG. 4 is a side view of a proximal end of the intestinal barrier sleeve according to at least one embodiment of the invention with the proximal end disposed in an expanded position. -
FIG. 5 is a front view of a proximal end of the intestinal barrier sleeve according to at least one embodiment of the invention with the proximal end disposed in an expanded position. - The present application provides generally an intestinal barrier sleeve that is expandable from at least one collapsed position to at least one expanded position for placement in a subject's gastrointestinal tract. Expansion of the expandable element results in the sleeve being lodged in the subject's GI tract therewith functionally retaining the sleeve therein. Although this design allows the sleeve to be installed without the need to affix or otherwise join the sleeve directly to the GI tract, for example, with a staple or suture, the sleeve may be so attached if desired. Referring to
FIG. 1 , in this regard, the intestinal barrier sleeve includes an expandingsection 106 coupled to an elongatedtubular section 104 atinterface 108. When expanded, the expandingsection 106 generally has a conical shape with a hole therein at the narrow end of the conical section, which is in communication with the lumen of thetubular section 104. The type of conical shape may vary. For example, the cone may be bowl or saucer shaped, funnel shaped, trumpet shaped, bell shaped, star shaped, etc., or a combination thereof, such as a bowl-star shape as shown. - The sleeve is preferably inserted endoscopically into the subject's gastrointestinal (GI) tract so that the
tubular section 104 extends through the pyloric sphincter of the subject'sstomach 100 into theduodenum 102 so that the pyloric sphincter acts directly onto thetubular section 104 of the sleeve at or just below theinterface 108. In this regard, the expandingsection 106 and optionally theinterface 108 are located within the pyloric canal of the subject'sstomach 100. Once expanded, the expandingsection 106 preferably provides sufficient resistance to retain the sleeve within the subject's GI tract without the need to anchor or otherwise affix the sleeve directly to the walls of the subject's GI tract. Thetubular section 104 extends into the subject's small intestine an amount sufficient to reduce further digestion and/or absorption of partially digested food by the small intestine. Thetubular section 104 preferably extends beyond theinterface 108 by about 20 inches to about 28 inches. In this regard, thetubular section 104 is preferably impermeable with respect to partially digested foods. Also, the distal end of the sleeve (the end of the tubular farthest away from the stomach, i.e., opposite the interface 108), may be weighted with several small focal weights on the end of the sleeve itself. This may mitigate the potential retrograde migration of the sleeve. - The sleeve may be manufactured from a variety and/or a combination of biocompatible and non-biocompatible materials, such as polyester, Gortex, polytetrafluoroethyline (PTFE), polyethelene, polypropylene, polyurethane, silicon, steel, stainless steel, titanium, Nitinol, or other shape memory alloys, copper, silver, gold, platinum, Kevlar fiber, carbon fiber, etc. Where non-biocompatible materials may come into contact with the anatomic structure, the components made from the non-biocompatible materials may be covered or coated with a biocompatible material. The sleeve is preferably made in part of a biocompatible polymer sufficiently flexible to allow a user to navigate therewith though a subject's GI tract to the site of interest. Moreover, the cross section of the
tubular section 104 has sufficiently thin walls so that in conjunction with the flexibility/elasticity of the material the sleeve will not interfere with the function of the subject's pyloric sphincter. - The intestinal barrier sleeve, particularly the expanding
section 106 is capable of being expanded between at least two positions: a collapsed position and an expanded position. In the collapsed position (FIGS. 2-3 ), the expandingsection 106 has a smaller profile (as compared to the expanded position (FIGS. 4-5 )) for the sleeve to be located in the GI track endoscopically, for example, through a catheter. The expandingsection 106 may be biased toward either position. That is, the expandingsection 106 may he biased toward the expanded position so that the expandingsection 106 remains expanded absent any compressive forces placed thereon. Similarly, thesection 106 may be biased toward the collapsed position so that thesection 106 remains collapsed absent any contrary forces. In the later, the expandingsection 106 may be fixed in the expanded position against the bias using, for example, using mechanical interlocking components. Alternatively, the structure ofsection 106 may be deformed beyond the elastic limits of the material so thatsection 106 is permanently deformed into the expanded position. - Referring to
FIGS. 2-5 , the expandingsection 106 preferably includes a plurality of petal-like elements section 106. The petal-like elements may vary in shape. For example, the petal-like elements may have an almond shape, as show, an elliptical shape, a rectangular shape, etc. These shapes may have planer or concave/convex surfaces. The petal-like elements backbone element 214 also extending radially from theinterface 108.Backbone elements 214 may be straight or preferably have an arc so that the shape ofsection 106 conforms to the subject's anatomy at site of interest. The petal-like elements ring structure 402. The petal-like elements webbing 216 to form the conical shaped noted above. Finally, thepetahlike elements bulbous element 210. Thebulbous element 210 may be spherical, ellipsoidal, or the like.Bulbous elements 210 may also include a through hole therein. - Referring to
FIGS. 2-3 , the petal-like elements section 106 to be placed in a compact collapsed position. In the event thatsection 106 is biased toward the expanded position, this collapsed position may be maintained, for example, by placing the sleeve within the lumen of a placement catheter. Other means may be used to maintain the collapsed position, including securing bulbous ends 210 to each other, for example, using the through holes therein. In these instances, expansion ofsection 106 in situ may be achieved by simply extruding the sleeve out from the placement catheter or otherwise removing the restrictive forces on the petal-like elements section 106 to assume an expanded position. The sleeve is preferably just as easily removed from the site of interest endoscopically. To do so, the restrictive forces are replaced on petal-like elements 202., 204, 206, 208 and/or the backbone thereof to draw these elements together at their outward ends. This may be achieved by pulling the sleeve into the placement catheter or otherwise placing restrictive forces on the petal-like elements - Referring to
FIG. 4 , the petal-like elements like elements section 106 expands, as shown inFIG. 5 . The petal-like elements tubular member 104 at theinterface 108 to facilitate the expansion/collapse of these elements. - The petal-
like elements webbing 216 are preferably connected continuously so that there are no breaks in between in the petal-like elements like elements backbone 214 thereof, thewebbing 216, and/or thering structure 402 as a unit. In this instance, these individual elements may be distinguished from each other by their respective thicknesses and the resulting performance characteristics thereof. For instance, thewebbing 216 may have a thickness so that it performs more like a film. That is, thewebbing 216 may functionally provide a flexible, impermeable layer that allows the petal-like elements webbing 216. The petal-like elements - The present application provides generally methods for treading ailments using the intestinal barrier sleeve(s) disclosed herein, including obesity, diabetes, as well as other ailments associated with or otherwise implicating the small intestine. These treatments may begin by preparing the subject being treated for an endoscopic procedure, which may include administering general anesthesia. The sleeve may then be passed endoscopically through the subject's GI tract so that the expanding
section 106 is located in the pyloric canal of the subject's stomach and so that thetubular section 104 extends into the subject's small intestine. At this time, expandingsection 106 is allowed or caused to expand, for example, by removing any restriction onsection 106. For example,section 106 may be extruded out from the placement catheter used to deliver the sleeve to the site of interest. Expansion ofsection 106 will keep the sleeve in place until removal is desired. The design of the sleeve allows the sleeve to be removed endoscopically with relative ease. To do so, the subject is similarly prepared for the endoscopic procedure and the sleeve is removed in the reverse direction from that in which the sleeve was placed. - While the foregoing invention has been described in some detail for purposes of clarity and understanding, it will be appreciated by one skilled in the art, from a reading of the disclosure, that various changes in form and detail can be made without departing from the true scope of the invention.
Claims (22)
1. A method for treating a subject with an ailment, the method comprising:
maintaining an intestinal barrier sleeve in a collapsed position, wherein the sleeve comprises an expanding section coupled to a tubular section at an interface therebetween, the expanding section expandable from at least the first collapsed position to at least one expanded position;
placing the sleeve with a collapsing section in the first collapsed position into a subject's gastrointestinal tract endoscopically;
expanding the expanding section within the subject's gastrointestinal tract therewith retaining the sleeve in the subject's gastrointestinal tract, wherein:
the expanding section has a trumpet shape with a hole therein at a narrow end of the trumpet shape, and wherein the trumpet shape is in communication with a lumen of the tubular section through the hole;
the expanding section comprises a plurality of rectangular-shaped elements that are deformed in the expanded position, the plurality of rectangular-shaped elements including backbone elements; and the expanding section further comprises a webbing that couples the backbone elements together.
2. The method of claim 1 , wherein the sleeve is placed in the subject's gastrointestinal tract so that the expanding section is located within the subject's pyloric canal.
3. The method of claim 2 , wherein the sleeve is placed in the subject's gastrointestinal tract so that the tubular section passes through the subject's pyloric sphincter and extends into the subject's small intestine.
4. The method of claim 3 , wherein the tubular section is comprised of at least in part of a flexible material.
5-6. (canceled)
7. The method of claim 1 , wherein the expanding section in the at least one expanded position provides resistance to retain the intestinal barrier sleeve within the subject's gastrointestinal tract without affixing the intestinal barrier sleeve directly to walls of the subject's gastrointestinal tract.
8. An intestinal barrier sleeve comprising an expanding anchor section coupled to a tubular section at an interface therebetween at a proximal end of the tubular section, the expanding anchor section expandable from at least one collapsed position to at least one expanded position, wherein in the collapsed position the expanded section has a compact shape that allows the sleeve to be placed into a subject's gastrointestinal tract endoscopically and in the expanded position the expanding anchor section retains the sleeve in the subject's stomach near the gastrointestinal tract, wherein:
the expanding anchor section has a trumpet shape with a hole therein at a narrow end of the trumpet shape, and wherein the trumpet shape is in communication with a lumen of the tubular section through the hole;
the expanding anchor section comprises a plurality of rectangular-shaped elements that are deformed in the expanded position, the plurality of rectangular-shaped elements including backbone elements; and
the expanding section further comprises a webbing that couples the backbone elements together.
9. The sleeve of claim 8 , wherein the expanding anchor section in the at least one expanded position provides resistance to retain the intestinal barrier sleeve within the subject's gastrointestinal tract without affixing the intestinal barrier sleeve directly to walls of the subject's gastrointestinal tract.
10. The sleeve of claim 8 , wherein the sleeve allows for placement in the subject's gastrointestinal tract so that the expanding anchor section is located within the subject's pyloric canal.
11. The sleeve of claim 10 , wherein the sleeve allows for placement in the subject's gastrointestinal tract so that the tubular section passes through the subject's pyloric sphincter and extends into the subject's small intestine.
12. The sleeve of claim 11 , wherein the tubular section is comprised of at least in part of flexible material.
13-14. (canceled)
15. An intestinal barrier sleeve comprising an expanding section coupled to a tubular section at an interface therebetween, the expanding section expandable from at least a first collapsed position to at least one expanded position, wherein:
the expanding section has a trumpet shape with a hole therein at a narrow end of the trumpet shape;
the trumpet shape is in communication with a lumen of the tubular section through the hole;
the expanding section comprises a plurality of rectangular-shaped elements that are deformed in the expanded position; and
the rectangular-shaped elements are interconnected with a webbing to form the trumpet shape.
16. The sleeve of claim 15 , wherein the expanding anchor section in the at least one expanded position provides resistance to retain the intestinal barrier sleeve within the subject's gastrointestinal tract without affixing the intestinal barrier sleeve directly to walls of the subject's gastrointestinal tract.
17. The sleeve of claim 15 , wherein the sleeve allows for placement in the subject's gastrointestinal tract so that the expanding anchor section is located within the subject's pyloric canal.
18. The sleeve of claim 17 , wherein the sleeve allows for placement in the subject's gastrointestinal tract so that the tubular section passes through the subject's pyloric sphincter and extends into the subject's small intestine.
19. The sleeve of claim 18 , wherein the tubular section is comprised of at least in part of a flexible material.
20. (canceled)
21. The sleeve of claim 8 , wherein the sleeve comprises a material selected from the group consisting of: polyester, Gortex, polytetratluoroethyline (PTFE), polyethelene, polypropylene, polyurethane, silicon, steel, stainless steel, titanium, Nitinol, or other shape memory alloys, copper, silver, gold, platinum, Kevlar fiber, and carbon fiber.
22. The sleeve of claim 8 , wherein the sleeve is covered or coated with a biocompatible material.
23. The sleeve of claim 15 , wherein the sleeve comprises a material selected from the group consisting of: polyester, Gortex, polytetratluoroethyline (PTFE), polyethelene, polypropylene, polyurethane, silicon, steel, stainless steel, titanium, Nitinol, or other shape memory alloys, copper, silver, gold, platinum, Kevlar fiber, and carbon fiber.
24. The sleeve of claim 15 , wherein the sleeve is covered or coated with a biocompatible material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/403,711 US20200000615A1 (en) | 2014-09-12 | 2019-05-06 | Intestinal barrier sleeve with expandable anchor section |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/484,828 US9579228B2 (en) | 2014-09-12 | 2014-09-12 | Intestinal barrier sleeve with expandable anchor section |
US15/408,668 US10327937B2 (en) | 2014-09-12 | 2017-01-18 | Intestinal barrier sleeve with expandable anchor section |
US16/403,711 US20200000615A1 (en) | 2014-09-12 | 2019-05-06 | Intestinal barrier sleeve with expandable anchor section |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/408,668 Continuation US10327937B2 (en) | 2014-09-12 | 2017-01-18 | Intestinal barrier sleeve with expandable anchor section |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200000615A1 true US20200000615A1 (en) | 2020-01-02 |
Family
ID=55459597
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/484,828 Active US9579228B2 (en) | 2014-09-12 | 2014-09-12 | Intestinal barrier sleeve with expandable anchor section |
US15/408,668 Active US10327937B2 (en) | 2014-09-12 | 2017-01-18 | Intestinal barrier sleeve with expandable anchor section |
US16/403,711 Abandoned US20200000615A1 (en) | 2014-09-12 | 2019-05-06 | Intestinal barrier sleeve with expandable anchor section |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/484,828 Active US9579228B2 (en) | 2014-09-12 | 2014-09-12 | Intestinal barrier sleeve with expandable anchor section |
US15/408,668 Active US10327937B2 (en) | 2014-09-12 | 2017-01-18 | Intestinal barrier sleeve with expandable anchor section |
Country Status (3)
Country | Link |
---|---|
US (3) | US9579228B2 (en) |
EP (2) | EP3673867B1 (en) |
WO (1) | WO2016040756A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10115808B2 (en) | 2016-11-29 | 2018-10-30 | Taiwan Semiconductor Manufacturing Company, Ltd. | finFET device and methods of forming |
CN107308534B (en) * | 2017-06-27 | 2021-02-26 | 杭州糖吉医疗科技有限公司 | Stomach divertor and antibiotic pipe of alimentary canal thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060009858A1 (en) * | 2004-07-09 | 2006-01-12 | Gi Dynamics, Inc. | Methods and devices for placing a gastrointestinal sleeve |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6675809B2 (en) * | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US7695446B2 (en) | 2002-12-02 | 2010-04-13 | Gi Dynamics, Inc. | Methods of treatment using a bariatric sleeve |
US7766973B2 (en) | 2005-01-19 | 2010-08-03 | Gi Dynamics, Inc. | Eversion resistant sleeves |
US7122058B2 (en) * | 2002-12-02 | 2006-10-17 | Gi Dynamics, Inc. | Anti-obesity devices |
US7608114B2 (en) | 2002-12-02 | 2009-10-27 | Gi Dynamics, Inc. | Bariatric sleeve |
US7025791B2 (en) | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
AU2004305450B2 (en) * | 2003-12-09 | 2009-01-08 | Gi Dynamics, Inc. | Intestinal sleeve |
WO2008154594A2 (en) * | 2007-06-11 | 2008-12-18 | Valentx, Inc. | Endoscopic delivery devices and methods |
WO2010115011A1 (en) * | 2009-04-03 | 2010-10-07 | Metamodix, Inc. | Modular gastrointestinal prostheses |
US9278019B2 (en) | 2009-04-03 | 2016-03-08 | Metamodix, Inc | Anchors and methods for intestinal bypass sleeves |
US20110004146A1 (en) * | 2009-07-01 | 2011-01-06 | E2 Llc | Systems and Methods for Treating of Obesity and Type 2 Diabetes |
US20110118650A1 (en) | 2009-11-18 | 2011-05-19 | Anteromed, Inc. | Method and apparatus for treating obesity and controlling weight gain and absorption of glucose in mammals |
US8636683B2 (en) * | 2010-01-14 | 2014-01-28 | Pavilion Medical Innovations, Llc | Systems and methods for bariatric therapy |
WO2011099940A1 (en) * | 2010-02-11 | 2011-08-18 | National University Of Singapore | System, device, and process for modifying absorption of matter by a gastrointestinal wall |
US8888732B2 (en) | 2011-03-11 | 2014-11-18 | Apollo Endosurgery, Inc. | Intraluminal sleeve with active agents |
FR2978345B1 (en) | 2011-07-25 | 2013-08-30 | Charam Khosrovaninejad | SURGICAL DEVICE FOR ANCHOR CONTROL IN INTESTINES. |
WO2013026474A1 (en) * | 2011-08-23 | 2013-02-28 | Ethicon Endo-Surgery, Inc. | Devices and methods for anchoring an endoluminal sleeve in the gi tract |
EP2967818B1 (en) * | 2013-03-15 | 2018-05-16 | Ez Off Weightloss, LLC | System for gastric restriction and malabsorption |
-
2014
- 2014-09-12 US US14/484,828 patent/US9579228B2/en active Active
-
2015
- 2015-09-11 EP EP20156369.9A patent/EP3673867B1/en active Active
- 2015-09-11 EP EP15839163.1A patent/EP3191017B1/en active Active
- 2015-09-11 WO PCT/US2015/049609 patent/WO2016040756A1/en active Application Filing
-
2017
- 2017-01-18 US US15/408,668 patent/US10327937B2/en active Active
-
2019
- 2019-05-06 US US16/403,711 patent/US20200000615A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060009858A1 (en) * | 2004-07-09 | 2006-01-12 | Gi Dynamics, Inc. | Methods and devices for placing a gastrointestinal sleeve |
Also Published As
Publication number | Publication date |
---|---|
US10327937B2 (en) | 2019-06-25 |
EP3191017B1 (en) | 2020-05-06 |
EP3191017A1 (en) | 2017-07-19 |
US20170119567A1 (en) | 2017-05-04 |
US9579228B2 (en) | 2017-02-28 |
EP3191017A4 (en) | 2018-04-25 |
US20160095732A1 (en) | 2016-04-07 |
EP3673867A1 (en) | 2020-07-01 |
WO2016040756A1 (en) | 2016-03-17 |
EP3673867B1 (en) | 2022-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE47902E1 (en) | Method and apparatus for treating obesity and controlling weight gain using self-expanding intragastric devices | |
JP7430830B2 (en) | Anchorless intragastric device for obesity treatment | |
US9839546B2 (en) | Apparatus and methods for treatment of morbid obesity | |
US20100249822A1 (en) | Method and apparatus for treating obesity and controlling weight gain using adjustable intragastric devices | |
US20140221899A1 (en) | Intragastric implant devices | |
EP2414026A2 (en) | Method and apparatus for treating obesity and controlling weight gain using self-expanding intragastric devices | |
CN106999647B (en) | Intragastric device for treating obesity | |
US20210401606A1 (en) | Flanged gastrointestinal devices and methods of use thereof | |
EP2222364A2 (en) | Biliary shunts, delivery systems, methods of using the same, and kits therefor | |
JP2017534340A5 (en) | ||
US20200000615A1 (en) | Intestinal barrier sleeve with expandable anchor section | |
US10219931B2 (en) | Obstruction device | |
EP3597156B1 (en) | Gastrointestinal implant and method for deploying the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |